TBPH Theravance Biopharma, Inc.

Fundamentals / CIK 0001583107 / USD

Theravance Biopharma, Inc. reported $104.3M in revenue and net income of $53.81M for the trailing twelve months ended June 30, 2026 (down 20.9% year over year), with a -4.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TBPH in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$889.7M$444.9M$0-$341.0MFY 2016 Revenue: $48.65MFY 2016 Net Income: -$190.7M2016FY 2017 Revenue: $15.39MFY 2017 Net Income: -$285.4M2017FY 2018 Revenue: $60.37MFY 2018 Net Income: -$215.5M2018FY 2019 Revenue: $73.41MFY 2019 Net Income: -$236.5M2019FY 2020 Revenue: $71.86MFY 2020 Net Income: -$278.0M2020FY 2021 Revenue: $55.31MFY 2021 Net Income: -$199.4M2021FY 2022 Revenue: $51.35MFY 2022 Net Income: $872.1M2022FY 2023 Revenue: $57.42MFY 2023 Net Income: -$55.19M2023FY 2024 Revenue: $64.38MFY 2024 Net Income: -$56.42M2024FY 2025 Revenue: $107.5MFY 2025 Net Income: $105.9M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $107.5M $64.38M $57.42M $51.35M $55.31M $71.86M $73.41M $60.37M $15.39M $48.65M
Cost of Revenue -- -- -- -- -- -- -- -- $6.03M $2.89M
Gross Profit -- -- -- -- -- -- -- -- $9.36M $45.75M
Research & Development $37.41M $37.64M $40.62M $63.39M $193.7M $261.0M $219.2M $201.3M $173.9M $141.7M
Selling, General & Admin $73.65M $69.17M $70.09M $67.07M $99.30M $108.5M $106.1M $97.06M $95.59M $84.51M
Total Operating Expenses $111.1M $111.3M $113.5M $143.3M $313.1M $369.5M $325.3M $299.1M $275.5M $229.1M
Operating Income -$3.60M -$46.95M -$56.03M -$91.96M -$257.8M -$297.6M -$251.9M -$238.8M -$260.1M -$180.5M
EBITDA -$2.10M -$45.35M -$54.13M -$89.36M -$254.3M -$294.3M -$248.6M -$235.6M -$256.1M -$177.3M
Interest Expense $2.46M $2.55M $2.35M $6.37M $8.55M $8.55M $31.86M $10.48M $8.55M $1.40M
Income Before Tax $129.2M -$44.61M -$49.27M -$92.81M -$265.2M -$303.3M -$241.7M -$226.1M -$271.7M -$180.6M
Income Tax Expense $23.35M $11.80M $5.92M $9.0K -$151K -$8.52M -$5.22M -$10.56M $13.69M $10.11M
Net Income $105.9M -$56.42M -$55.19M $872.1M -$199.4M -$278.0M -$236.5M -$215.5M -$285.4M -$190.7M
Basic EPS $2.10 -$1.15 -$1.00 $11.85 -$2.87 -$4.46 -$4.25 -$3.99 -$5.45 -$4.26
Diluted EPS $2.06 -$1.15 -$1.00 $11.85 -$2.87 -$4.46 -$4.25 -$3.99 -$5.45 -$4.26
Basic Shares Outstanding 50.3M 48.8M 55.3M 73.6M 69.5M 62.3M 55.6M 55.1M 53.7M 44.7M
Diluted Shares Outstanding 51.5M 48.8M 55.3M 73.6M 69.5M 62.3M 55.6M 54.0M 52.4M 44.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue $20.73M $17.70M $45.89M $19.99M $26.20M $15.39M $18.75M $16.87M
Research & Development $4.71M $5.83M $7.36M $8.11M $10.49M $11.45M $9.45M $9.27M
Selling, General & Admin $14.18M $17.72M $18.52M $18.33M $18.43M $18.37M $18.50M $16.88M
Total Operating Expenses $29.01M $27.18M $25.88M $26.45M $28.92M $29.82M $27.95M $27.70M
Operating Income -$8.28M -$9.48M $20.01M -$6.46M -$2.73M -$14.43M -$9.20M -$10.84M
Interest Expense -- -- $582K $573K $663K $643K $643K $630K
Income Before Tax -$4.79M -$6.47M $73.07M -$2.89M $73.21M -$14.14M -$8.94M -$10.05M
Income Tax Expense $1.11M -$1.54M $12.04M -$6.50M $18.37M -$559K $6.59M $2.65M
Net Income -$5.90M -$4.93M $61.02M $3.62M $54.84M -$13.58M -$15.53M -$12.70M
Basic EPS -$0.11 -$0.10 $1.20 $0.07 $1.09 -$0.27 -$0.31 -$0.26
Diluted EPS -$0.11 -$0.10 $1.15 $0.07 $1.08 -$0.27 -$0.31 -$0.26
Basic Shares Outstanding 51.7M 51.3M -- 50.5M 50.2M 49.7M -- 49.0M
Diluted Shares Outstanding 51.7M 51.3M -- 51.9M 50.7M 49.7M -- 49.0M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $167.8M $37.80M $39.55M $298.2M $89.96M $81.47M $58.06M $378.0M $88.98M $344.7M
Short-Term Investments $147.6M $50.55M $62.88M $29.31M $83.51M $211.5M $222.8M $127.3M $259.6M $156.4M
Cash & Short-Term Investments $315.4M $88.35M $102.4M $327.5M $173.5M $292.9M $280.8M $505.3M $348.6M $501.1M
Accounts Receivable, Net -- -- -- -- -- -- -- $620K $2.25M $646K
Inventory -- -- -- -- -- -- -- $0 $16.83M $12.22M
Total Current Assets $418.5M $161.1M $133.5M $353.5M $249.9M $393.3M $338.5M $532.8M $378.7M $528.5M
Property, Plant & Equipment, Net $5.89M $7.42M $9.07M $11.88M $13.66M $16.42M $12.64M $13.18M $10.16M $8.46M
Long-Term Investments $11.13M -- -- -- -- -- $4.99M $11.87M $41.59M $91.56M
Other Non-Current Assets $24.88M $12.29M $8.07M $6.90M $3.23M $2.45M $1.59M $1.53M $1.88M $1.89M
Total Non-Current Assets $67.11M $193.1M $248.5M $253.9M $124.9M $75.72M $70.34M $27.41M $62.65M $110.8M
Total Assets $485.6M $354.2M $382.0M $607.4M $374.8M $469.1M $408.8M $560.2M $441.4M $639.3M
Accounts Payable $2.57M $2.24M $1.52M $1.55M $3.10M $6.78M $4.76M $9.03M $5.92M $1.73M
Deferred Revenue (Current) -- -- -- $24K $98K $11.52M $31.57M $43.40M $125K $152K
Total Current Liabilities $38.30M $32.09M $24.77M $28.71M $58.59M $123.6M $111.7M $98.55M $62.55M $49.27M
Long-Term Debt -- -- $0 -- $616.3M $619.2M $455.0M $454.4M $223.7M --
Deferred Revenue (Non-Current) -- -- -- $192K $310K $348K $6.76M $26.18M $1.44M --
Other Non-Current Liabilities $313K $1.89M $5.92M $1.66M $2.18M $1.83M $21.29M $24.76M $34.82M $13.11M
Total Non-Current Liabilities $150.5M $146.5M $144.2M $136.9M $654.8M $649.2M $521.0M $513.3M $263.7M $239.8M
Total Liabilities $188.8M $178.6M $169.0M $165.6M $713.4M $772.8M $632.7M $611.8M $326.2M $289.0M
Total Debt (incl. Leases) $42.70M $49.82M $49.16M $52.16M $669.5M $676.3M $510.5M $454.4M $223.7M --
Common Stock $1.0K -- -- $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K
Retained Earnings -$859.6M -$965.5M -$909.1M -$853.9M -$1.73B -$1.53B -$1.25B -$1.01B -$797.7M -$512.2M
Accumulated Other Comp. Income $61K $7.0K -$65K -$15K -- $47K $145K -$166K -$733K -$253K
Total Stockholders' Equity $296.7M $175.5M $213.0M $441.8M -$338.6M -$303.8M -$223.8M -$51.59M $115.2M $350.2M
Total Equity $296.7M $175.5M $213.0M $441.8M -$338.6M -$303.8M -$223.8M -$51.59M $115.2M $350.2M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $219.8M $288.1M $167.8M $174.8M $281.9M $110.6M $37.80M $23.38M
Short-Term Investments $167.9M $106.6M $147.6M $154.9M $56.88M $20.24M $50.55M $67.98M
Cash & Short-Term Investments $387.7M $394.7M $315.4M $329.7M $338.8M $130.9M $88.35M $91.36M
Total Current Assets $416.7M $417.6M $418.5M $354.7M $366.3M $150.3M $161.1M $116.5M
Property, Plant & Equipment, Net $5.17M $5.54M $5.89M $6.26M $6.64M $7.03M $7.42M $7.79M
Long-Term Investments -- -- $11.13M $3.03M -- -- -- --
Other Non-Current Assets $25.18M $25.30M $24.88M $25.19M $25.77M $13.82M $12.29M $7.47M
Total Non-Current Assets $53.11M $54.68M $67.11M $60.76M $59.74M $193.3M $193.1M $239.6M
Total Assets $469.8M $472.3M $485.6M $415.5M $426.0M $343.6M $354.2M $356.1M
Accounts Payable $652K $1.10M $2.57M $2.21M $1.68M $2.41M $2.24M $1.45M
Total Current Liabilities $30.77M $31.77M $38.30M $37.41M $54.63M $31.50M $32.09M $23.43M
Other Non-Current Liabilities $244K $244K $313K $313K $1.55M $1.29M $1.89M $4.98M
Total Non-Current Liabilities $149.3M $149.9M $150.5M $145.4M $146.6M $146.1M $146.5M $147.0M
Total Liabilities $180.1M $181.7M $188.8M $182.8M $201.2M $177.6M $178.6M $170.5M
Total Debt (incl. Leases) $38.57M $40.50M $42.70M $44.59M $46.46M $48.16M $49.82M $44.98M
Common Stock $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K -- --
Retained Earnings -$870.5M -$864.6M -$859.6M -$920.7M -$924.3M -$979.1M -$965.5M -$950.0M
Accumulated Other Comp. Income -$76K -$62K $61K $32K -$10K -- $7.0K $50K
Total Stockholders' Equity $289.7M $290.6M $296.7M $232.7M $224.8M $166.0M $175.5M $185.7M
Total Equity $289.7M $290.6M $296.7M $232.7M $224.8M $166.0M $175.5M $185.7M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $105.9M -$56.42M -$55.19M $872.1M -$199.4M -$278.0M -$236.5M -$215.5M -$285.4M -$190.7M
Depreciation & Amortization $1.50M $1.60M $1.90M $2.60M $3.50M $3.30M $3.30M $3.17M $4.03M $3.12M
Stock-Based Compensation $18.48M $21.39M $25.37M $39.73M $62.06M $62.98M $60.45M $51.31M $49.15M $41.17M
Change in Receivables -- -- -- -- -- -- $620K $1.63M -$1.61M $1.28M
Change in Inventory -- -- -- -- -- -- -- -$1.63M -$7.30M -$3.18M
Change in Payables $326K $750K $6.0K -$1.61M -$3.53M $3.66M -$4.27M $3.58M $3.80M -$16.44M
Operating Cash Flow $238.5M -$11.54M -$27.00M -$187.0M -$207.9M -$250.4M -$238.2M -$112.9M -$201.1M -$98.99M
Capital Expenditure -$42K -$332K -$2.49M -$572K -$3.41M -$6.62M -$3.18M -$7.24M -$2.41M -$2.13M
Free Cash Flow $238.5M -$11.87M -$29.48M -$187.6M -$211.3M -$257.0M -$241.4M -$120.1M -$203.5M -$101.1M
Purchases of Investments -$248.2M -$140.7M -$134.5M -$103.1M -$158.3M -$402.0M -$423.9M -$183.3M -$288.8M -$237.6M
Investing Cash Flow -$105.3M $12.28M -$32.70M $1.15B $124.5M $10.72M -$83.05M $176.7M -$56.33M -$148.2M
Common Stock Issued $20K $99K -- -- $108.2M $139.9M -- -- $0 $253.0M
Share Repurchases -- -$445K -$197.1M -$128.8M -- -- -- -- -- --
Financing Cash Flow -$3.25M -$2.50M -$198.9M -$758.8M $91.86M $263.1M $1.29M $225.2M $1.66M $479.2M
Net Change in Cash $130.0M -$1.75M -$258.6M $208.2M $8.50M $23.40M -$320.0M $289.0M -$255.7M $232.0M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income -$5.90M -$4.93M $61.02M $3.62M $54.84M -$13.58M -$15.53M -$12.70M
Stock-Based Compensation $5.99M $4.50M $4.48M $4.58M $4.54M $4.88M $5.83M $4.96M
Change in Payables -$448K -$1.47M $355K $538K -$733K $166K $788K -$220K
Operating Cash Flow -$6.96M $73.28M -$6.06M -$6.51M $208.1M $43.04M -$902K -$5.20M
Capital Expenditure -- -- -- -- -- -- -$190K -$15K
Free Cash Flow -- -- -- -- -- -- -$1.09M -$5.21M
Purchases of Investments -$101.9M -$43.41M -$64.93M -$124.7M -$56.57M -$1.97M -$37.72M -$44.88M
Investing Cash Flow -$60.40M $52.59M $588K -$100.2M -$36.26M $30.63M $15.69M -$17.40M
Common Stock Issued -- -- $0 $0 $0 $20K -- --
Share Repurchases -- -- -- -- -- -- $0 $0
Financing Cash Flow -$967K -$5.58M -$1.49M -$400K -$503K -$854K -$365K -$372K
Net Change in Cash -$68.33M $120.3M -$6.97M -$107.2M $171.3M $72.82M $14.42M -$22.97M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- -- -- -- -- -- 60.8% 94.1%
Operating Margin -3.4% -72.9% -97.6% -179.1% -466.1% -414.2% -343.1% -395.5% -1690.6% -371.0%
Net Profit Margin 98.5% -87.6% -96.1% 1698.5% -360.6% -386.9% -322.1% -357.0% -1855.0% -391.9%
Return on Equity (ROE) 35.7% -32.1% -25.9% 197.4% -- -- -- -- -247.8% -54.4%
Return on Assets (ROA) 21.8% -15.9% -14.4% 143.6% -53.2% -59.3% -57.8% -38.5% -64.7% -29.8%
Current Ratio 10.93x 5.02x 5.39x 12.31x 4.26x 3.18x 3.03x 5.41x 6.05x 10.73x
Quick Ratio 8.23x 2.75x 4.14x 11.40x 2.96x 2.37x 2.51x 5.41x 5.79x 10.48x
Debt to Equity 0.14x 0.28x 0.23x 0.12x -- -- -- -- 1.94x --
Revenue Growth (YoY) +66.9% +12.1% +11.8% -7.2% -23.0% -2.1% +21.6% +292.4% -68.4% +15.5%
Gross Profit Growth (YoY) -- -- -- -- -- -- -- -- -79.6% +22.1%
Net Income Growth (YoY) -- -- -106.3% -- -- -- -- -- -- --
EPS Growth (YoY) -- -- -108.4% -- -- -- -- -- -- --
5Y Revenue / Share Growth +85.3% -0.2% -5.3% +143.5% -26.8% -6.6% +258.7% +15294.7% -93.0% --
10Y Revenue / Share Growth +73.1% +258.1% +14483.3% -83.0% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Operating Margin -4.0% 1.2% -3.4% -40.9% -48.2% -76.9% -72.9% -69.6%
Net Profit Margin 51.6% 104.3% 98.5% 36.5% 16.9% -89.4% -87.6% -78.2%
Return on Equity (ROE) 18.6% 39.4% 35.7% 12.6% 5.8% -35.1% -32.1% -26.6%
Return on Assets (ROA) 11.5% 24.3% 21.8% 7.1% 3.1% -17.0% -15.9% -13.9%
Current Ratio 13.54x 13.14x 10.93x 9.48x 6.70x 4.77x 5.02x 4.97x
Quick Ratio 12.60x 12.42x 8.23x 8.81x 6.20x 4.15x 2.75x 3.90x
Debt to Equity 0.13x 0.14x 0.14x 0.19x 0.21x 0.29x 0.28x 0.24x
Revenue Growth (YoY) -20.9% +15.0% +144.7% +18.5% +83.7% +6.1% +6.8% +7.5%
Net Income Growth (YoY) -110.8% -- -- -- -- -- -- --
EPS Growth (YoY) -110.1% -- -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -103.3% +70.3% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001583107) · from December 31, 2012 Data through June 30, 2026 · synced Nov 20, 2026, 05:31 UTC · Open in terminal